OMEPRAZOLE EXTENDED-RELEASE CAPSULES

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 2 bottles of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, with NSN 6505016247068 and NDC 00781-2868-92, at a total contract value of $101.60. The order, issued as SPE2DP-26-F-6918 and awarded on July 1, 2026, specifies delivery to Kunsan Air Base, Republic of Korea, under FOB Destination terms, meaning the contractor assumes all freight costs and risks until the goods arrive at the designated location. The delivery is due on a single date, July 1, 2026, with no flexibility in quantity—plus or minus zero percent—and acceptance occurs at the destination by the Government. Packaging and marking must follow specified identifiers: Block 1 must display the base contract number SPE2DX-25-D-9900, Block 2 the delivery order SPE2DP-26-F-6918, and all documents must include the Document Identifier Code 9A266, Freight Classification 26100, and Invoice Processing Date of May 2, 2025. Compliance with DLAD PROC NOTE C19 and C20 for transportation is required, though no explicit MIL-STDs are cited. The awardee is certified as a small, small disadvantaged, and women-owned business, triggering compliance obligations under small business programs. Payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, using standard DoD invoicing procedures likely through WAWF. Contract administration is managed by Lisa Quinn, the contracting officer at DLA Troop Support, with Shairy M. Cartagena as the local administrative contact. No additional clauses, special requirements, evaluation factors, or attachments are detailed beyond the core delivery terms and small business certifications, indicating a straightforward, low-value commercial acquisition executed under an existing blanket purchase agreement.